Viveon Health Acquisition Corp. to Merge with Suneva Medical

SUNation Energy to Acquire Suniva via Definitive Reverse Merger Agreement

June 8, 2026

Energy

SUNation Energy and Suniva have signed a definitive reverse merger agreement in which Suniva will merge with a wholly owned subsidiary of SUNation. The combined company is expected to operate under the Suniva name and continue SUNation’s Nasdaq listing, with Suniva stockholders expected to own a majority of the post-merger equity.

Keen Vision Acquisition Corporation to Merge with Medera Inc. (NASDAQ Listing)

September 5, 2024

Biotechnology

Keen Vision Acquisition Corporation (KVAC) entered into a definitive merger agreement with clinical-stage biotechnology company Medera Inc. to take Medera public on Nasdaq, expected to close in the fourth quarter of 2024. The business combination is expected to provide funds that will accelerate Medera’s three most advanced AAV-based gene therapy programs.

SunMed Acquires Vyaire Medical's Respiratory & Anesthesia Consumables Business

March 28, 2023

Medical Devices

SunMed, a Frazier Healthcare Partners–backed medical-device manufacturer headquartered in Grand Rapids, Michigan, agreed to acquire Vyaire Medical’s respiratory and anesthesia consumables business, a unit that makes airway management and operative-care consumables. The deal—announced March 28, 2023 and completed May 1, 2023—expands SunMed’s product portfolio, manufacturing footprint and global reach; terms were not disclosed.

Chardan Healthcare Acquisition 2 Corp. Completes Business Combination with Renovacor, Inc.

September 2, 2021

Biotechnology

Renovacor, an early‑stage biotechnology company developing AAV‑based gene therapies for BAG3‑associated cardiovascular and CNS diseases, closed a business combination with special purpose acquisition company Chardan Healthcare Acquisition 2 Corp. (CHAQ) and will begin trading on the New York Stock Exchange as Renovacor, Inc., with approximately $95.1 million of gross proceeds (including a $30.0 million PIPE) to fund clinical development into 2023. The transaction preserves Renovacor’s existing management team and provides public-market access and capital to advance its lead program, REN‑001, toward IND submission and a Phase I/II trial.

Vesper Healthcare Acquisition Corp. Merges with The HydraFacial Company (BeautyHealth)

May 5, 2021

Healthcare Services

Vesper Healthcare Acquisition Corp. completed a business combination with The HydraFacial Company, taking the business public as The Beauty Health Company (ticker: SKIN) in a transaction that values HydraFacial at a pro forma enterprise value of $1.1 billion. The deal included a fully committed $350 million PIPE anchored by institutional investors (including Fidelity, Redmile, Principal, Camber and Woodline), and Linden Capital Partners and DW Healthcare Partners remain meaningful shareholders with management continuing in place.

Newborn Acquisition Corp Completes Business Combination with Nuvve; Nuvve Begins Trading on Nasdaq

March 22, 2021

Renewable Energy

Nuvve Holding Corp. completed a business combination with Newborn Acquisition Corp., enabling Nuvve to begin trading on the Nasdaq under the ticker NVVE. The transaction provided Nuvve approximately $62 million in cash proceeds (including a related private placement) to accelerate development and commercial deployment of its vehicle-to-grid (V2G) technology and related services.